medigraphic.com
ISSN 0210-5187 (Electronic)

2008, Number 3

<< Back Next >>

Med Cutan Iber Lat Am 2008; 36 (3)

Merkel cell carcinoma of the cheek

Viola A, Martínez M, Larre BA, Laporte M, Anda G, Bazzano C

Language: Spanish
References: 15
Page: 142-145
PDF size: 265.29 Kb.


ABSTRACT

The Merkel cell carcinoma (MCC) is an infrequent neuroendocrine neoplasm with a high specific mortality rate. Its diagnosis is supported by the clinic, histopathology and immunohistochemistry. A 83 year old female patient who has had a tumor on her left cheek for 45 days is reported. With a presumptive keratoacanthoma diagnosis, exeresis biopsy was performed. Histopathology and immunohistochemistry studies suggest MCC. No invasion was found and surgical resection followed. Due to the patient’s age and facial flaccidness, double M-Plasty was chosen for its simplicity, reliability and minimal probability of postsurgical complications.


REFERENCES

  1. Hodgson N. Merkel cell carcinoma: changing incidence trends. J Surg Oncol 2005;89:1-4.

  2. Angelli M, Clegg L. Epydemiology of primary Merkel cell carcinoma in the United States. J Am Academy Dermatol 2003;49:832-41.

  3. Bickle K, Glass L, Messina JL, Fenske N, Siegrist K. Merkel cell carcinoma: a clinical, histopathologic, and immunohistochemical review. Semin Cutan Med Surg 2004;23:46-53.

  4. Tai PT, Yu E, Winquist E et al. Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases. J Clin Oncol 2000;18:2493-9.

  5. Krasagakis K, Tosca A. Overview of Merkel cell carcinoma and recent advances in research. Int J Dermatol 2003;42:669-76.

  6. King M, Osswald M. Adjuvant chemotherapy for Merkel cell carcinoma. Am J Clin Oncol 2005;28:634.

  7. Eng T, Boersma M, Fuller C, Cavanaugh S, Valenzuela F, Herman T. Treatment of Merkel cell carcinoma. Am J Clin Oncol 2004;27:510-5.

  8. Allen PJ, Bowne BW, Jaques DP et al. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol ????;23:2300-9.

  9. Haag ML, Glass LF, Fenske NA. Merkel cell carcinoma. Diagnosis and treatment. Dermatol Surg 1995;21:669-83.

  10. Hattori H. Merkel cell carcinoma composed of small, intermediate and squamous cell showing mutually exclusive expresión of neuroendocrine markers and cytokeratin 20. Br J Dermatol 2003;148:183-5.

  11. Tanaka Y, Sano T, Qian ZR, Hirokawa M. Expression of adhesion molecules and cytokeratin 20 in merkel cell carcinomas. Endocr Pathol 2004;15:117-29.

  12. Acebo E, Vidaurrazaga N, Varas C, Burgos-Bretones JJ, Díaz-Pérez JL. Merkel cell carcinoma: a clinicopathological study of 11 cases. J Eur Acad Dermatol 2005;19:546-51.

  13. Lehrer M, Hershock D, Ming M. Merkel cell carcinoma. Curr Treat Options Oncol 2004;5:195-9.

  14. McAfee W, Morris C, Mendenhall C, Werning J, Mendenhall N, Mendenhall W. Merkel cell carcinoma: treatment and outcomes. Cancer 2005;104:1761-4.

  15. Poulsen M, Rischin D, Porter I, Walpole E, Harvey J, Hamilton C, Keller J, Tripcony L Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin? Int J Radiat Oncol Biol Phys 2006;64:114-9




2020     |     www.medigraphic.com